NCT02034019已完成3 期
Phase 3 Study Evaluating Safety and Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract Surgery
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 247
- 试验地点
- 1
- 主要终点
- Absence of Cells in Anterior Chamber of the Study Eye
研究概览
简要总结
To evaluate the safety and efficacy of OTX-DP as a sustained release drug (dexamethasone) depot when placed in the canaliculus of the eyelid for the treatment of post-surgical inflammation and pain in subjects who have undergone cataract extraction with intra-ocular lens implantation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Has a cataract and is expected to undergo clear corneal cataract surgery with phacoemulsification and implantation of a posterior chamber intraocular lens
- •Has a potential post-operative pinhole corrected Snellen VA of at least 20/200 or better in both eyes
排除标准
- •Any intraocular inflammation in the study eye present during the screening slit lamp examination
- •Score greater than "0" on the Ocular Pain Assessment in the study eye at Screening
- •Any intraocular inflammation in the study eye present during the screening slit lamp examination
研究组 & 干预措施
OTX-DP (Dexamethasone Punctum Plug)
Active Comparator
Resorbable hydrogel drug delivery vehicle containing dexamethasone
干预措施: Dexamethasone (Drug)
OTX-DP (Dexamethasone Punctum Plug)
Active Comparator
Resorbable hydrogel drug delivery vehicle containing dexamethasone
干预措施: Punctum Plug (Drug)
PVPP (Placebo Punctum Plug)
Placebo Comparator
Resorbable hydrogel drug delivery vehicle containing no drug
干预措施: Punctum Plug (Drug)
结局指标
主要结局
Absence of Cells in Anterior Chamber of the Study Eye
时间窗: Day 14
Absence of Pain in Study Eye
时间窗: Day 8
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Phase II Study Evaluating Safety/Efficacy of OTX-DP for Treatment of Ocular Inflammation and Pain After Cataract SurgeryOcular Inflammation and PainNCT01666210Ocular Therapeutix, Inc.60
已完成
3 期
OTX-15:003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract SurgeryPost-Surgical Ocular PainPost-Surgical Ocular InflammationNCT02736175Ocular Therapeutix, Inc.438
已完成
3 期
OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract SurgeryPost-Surgical Ocular PainPost-Surgical Ocular InflammationNCT02089113Ocular Therapeutix, Inc.241
已完成
2 期
OTX-14-006: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Dry EyeDry EyeNCT02468700Ocular Therapeutix, Inc.43
已完成
3 期
OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic ConjunctivitisChronic Allergic ConjunctivitisNCT02988882Ocular Therapeutix, Inc.86